Nomad Power Solutions, Inc. SEC filings NMAD
Nomad Power Solutions, Inc. has 528 filings in SEC EDGAR's recent list, going back to Aug 3, 2005. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jun 4, 2026 | — |
| 424B5 | Prospectus supplement | Dec 19, 2025 | — |
| S-1/A | Amended registration statement | Jul 10, 2025 | — |
| 424B5 | Prospectus supplement | Jul 8, 2025 | — |
| S-1/A | Amended registration statement | Jun 24, 2025 | — |
| S-1 | Registration statement | Jun 18, 2025 | — |
| 424B4 | Prospectus | Apr 11, 2025 | — |
| S-1/A | Amended registration statement | Apr 9, 2025 | — |
| S-1 | Registration statement | Apr 4, 2025 | — |
| 424B5 | Prospectus supplement | Feb 12, 2025 | — |
| 424B5 | Prospectus supplement | Jan 10, 2025 | — |
| S-1/A | Amended registration statement | Nov 5, 2024 | — |
| S-1/A | Amended registration statement | Nov 1, 2024 | — |
| S-1 | Registration statement | Oct 23, 2024 | — |
| 424B5 | Prospectus supplement | May 3, 2024 | — |
| 424B5 | Prospectus supplement | May 3, 2024 | — |
| S-3/A | Filing | Apr 30, 2024 | — |
| S-3 | Shelf registration | Apr 23, 2024 | — |
| S-3 | Shelf registration | Aug 11, 2023 | — |
| 424B5 | Prospectus supplement | Jul 20, 2023 | — |
| 424B5 | Prospectus supplement | May 10, 2023 | — |
| S-8 | Employee stock plan registration | Dec 19, 2022 | — |
| 424B5 | Prospectus supplement | Apr 14, 2022 | — |
| 424B5 | Prospectus supplement | Sep 20, 2021 | — |
| S-8 | Employee stock plan registration | Apr 21, 2021 | — |
| 424B5 | Prospectus supplement | Mar 1, 2021 | — |
| S-3 | Shelf registration | Jan 26, 2021 | — |
| 424B4 | Prospectus | Nov 27, 2020 | — |
| S-1/A | Amended registration statement | Nov 16, 2020 | — |
| S-1/A | Amended registration statement | Nov 2, 2020 | — |
| S-1/A | Amended registration statement | Oct 13, 2020 | — |
| S-1 | Registration statement | Sep 3, 2020 | — |
| 424B3 | Prospectus | May 17, 2007 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NMAD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boca Raton, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1335105
- Former names
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (until Jul 2, 2026); SRKP 7 INC (until Dec 1, 2006)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.